Pfizer unified investigator and provider data on Reltio with AI-assisted stewardship to speed clinical study start-up.
Pfizer's clinical, contracting and enterprise teams worked in disconnected data, forcing manual due diligence research. It deployed the Reltio Context Intelligence Platform to bridge investigator, site and affiliation profiles with AI-assisted stewardship and human review. The page reports a 25% projected study start-up time reduction, an 80-90% due diligence time reduction goal with an AI agent and a goal of cutting a 250K+ record steward backlog by 30-40%.
Reltio is a cloud master data management and data unification vendor, used by pharma to build a single view of HCPs, HCOs, patients and investigators
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Reltio on its own site — read the original case study on reltio.com ↗
Related use cases
- 01Clario consolidated post-merger clinical trial and commercial data on Reltio and Amazon S3.
- 02AstraZeneca replaced 67 legacy MDM instances with three cloud Reltio hubs feeding Veeva CRM.
- 03AbbVie moved HCP and HCO master data to Reltio and used it to absorb the Allergan acquisition.
- 04Transforming Content Operations for 2x Faster Time to Market
- 05Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 06How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster